Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer
Clinical trial NCT01149343 · COMPLETED
Trial details
- NCT number
- NCT01149343
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-02
- Primary completion
- 2014-02-11
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.